Bad to the bone: B cell acute lymphoblastic leukemia cells mediate bone destruction
Related Experiment Video
Updated: Nov 18, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Sujeetha A Rajakumar1,2, Jayne S Danska1,2,3
1Program in Genetics and Genome Biology, Hospital for Sick Children Research Institute, Toronto, Canada.
Abstract:
Skeletal morbidities continue to cause acute and long-term burdens for B-ALL patients underscoring the need to identify the mechanisms underlying these processes and to develop effective therapies. Our recent findings demonstrated that B-ALL cells isolated at patient diagnosis can cause bone destruction and have identified the receptor activator of nuclear factor κ-B (RANK-RANKL) ligand axis as a critical effector of these effects.
Related Concept Videos
Cells of the Adaptive Immune Response
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Osteoclasts in Bone Remodeling
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

